nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketobemidone—Pethidine—SLC6A4—endogenous depression	0.0298	0.587	CrCbGaD
Ketobemidone—OPRD1—forebrain—endogenous depression	0.0231	0.067	CbGeAlD
Ketobemidone—OPRK1—forebrain—endogenous depression	0.0222	0.0642	CbGeAlD
Ketobemidone—Pethidine—CYP2D6—endogenous depression	0.021	0.413	CrCbGaD
Ketobemidone—UGT1A9—endocrine gland—endogenous depression	0.017	0.0491	CbGeAlD
Ketobemidone—OPRM1—brainstem—endogenous depression	0.0163	0.0473	CbGeAlD
Ketobemidone—OPRM1—forebrain—endogenous depression	0.0158	0.0457	CbGeAlD
Ketobemidone—OPRD1—nervous system—endogenous depression	0.0125	0.0364	CbGeAlD
Ketobemidone—OPRD1—central nervous system—endogenous depression	0.0121	0.035	CbGeAlD
Ketobemidone—OPRK1—nervous system—endogenous depression	0.012	0.0349	CbGeAlD
Ketobemidone—OPRK1—central nervous system—endogenous depression	0.0116	0.0336	CbGeAlD
Ketobemidone—OPRK1—cerebellum—endogenous depression	0.0113	0.0328	CbGeAlD
Ketobemidone—OPRM1—midbrain—endogenous depression	0.0104	0.0302	CbGeAlD
Ketobemidone—OPRD1—brain—endogenous depression	0.00959	0.0278	CbGeAlD
Ketobemidone—OPRK1—brain—endogenous depression	0.00919	0.0266	CbGeAlD
Ketobemidone—OPRM1—endocrine gland—endogenous depression	0.00914	0.0265	CbGeAlD
Ketobemidone—OPRM1—nervous system—endogenous depression	0.00856	0.0248	CbGeAlD
Ketobemidone—OPRM1—central nervous system—endogenous depression	0.00824	0.0239	CbGeAlD
Ketobemidone—CYP2B6—adrenal cortex—endogenous depression	0.00788	0.0228	CbGeAlD
Ketobemidone—PTGS1—forebrain—endogenous depression	0.00769	0.0223	CbGeAlD
Ketobemidone—CYP2B6—cardiovascular system—endogenous depression	0.00719	0.0208	CbGeAlD
Ketobemidone—CYP2C9—cardiovascular system—endogenous depression	0.00712	0.0206	CbGeAlD
Ketobemidone—CYP2C8—pituitary gland—endogenous depression	0.0071	0.0206	CbGeAlD
Ketobemidone—OPRM1—brain—endogenous depression	0.00654	0.019	CbGeAlD
Ketobemidone—PTGS1—cardiovascular system—endogenous depression	0.0065	0.0188	CbGeAlD
Ketobemidone—CYP2C19—endocrine gland—endogenous depression	0.0063	0.0183	CbGeAlD
Ketobemidone—PTGS1—pituitary gland—endogenous depression	0.00576	0.0167	CbGeAlD
Ketobemidone—CYP2B6—adrenal gland—endogenous depression	0.00569	0.0165	CbGeAlD
Ketobemidone—CYP2C8—endocrine gland—endogenous depression	0.0055	0.0159	CbGeAlD
Ketobemidone—PTGS1—adrenal gland—endogenous depression	0.00514	0.0149	CbGeAlD
Ketobemidone—PTGS1—thyroid gland—endogenous depression	0.00496	0.0144	CbGeAlD
Ketobemidone—CYP2B6—endocrine gland—endogenous depression	0.00493	0.0143	CbGeAlD
Ketobemidone—CYP2C9—endocrine gland—endogenous depression	0.00488	0.0142	CbGeAlD
Ketobemidone—CYP2B6—nervous system—endogenous depression	0.00462	0.0134	CbGeAlD
Ketobemidone—PTGS1—endocrine gland—endogenous depression	0.00446	0.0129	CbGeAlD
Ketobemidone—CYP2B6—central nervous system—endogenous depression	0.00444	0.0129	CbGeAlD
Ketobemidone—PTGS1—nervous system—endogenous depression	0.00417	0.0121	CbGeAlD
Ketobemidone—PTGS1—central nervous system—endogenous depression	0.00402	0.0116	CbGeAlD
Ketobemidone—CYP2C8—brain—endogenous depression	0.00393	0.0114	CbGeAlD
Ketobemidone—CYP3A4—endocrine gland—endogenous depression	0.00372	0.0108	CbGeAlD
Ketobemidone—CYP2B6—brain—endogenous depression	0.00353	0.0102	CbGeAlD
Ketobemidone—CYP3A4—nervous system—endogenous depression	0.00349	0.0101	CbGeAlD
Ketobemidone—CYP3A4—central nervous system—endogenous depression	0.00336	0.00973	CbGeAlD
Ketobemidone—PTGS1—brain—endogenous depression	0.00319	0.00925	CbGeAlD
Ketobemidone—UGT1A9—Biological oxidations—MAOA—endogenous depression	0.00241	0.00399	CbGpPWpGaD
Ketobemidone—PTGS1—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.00241	0.00398	CbGpPWpGaD
Ketobemidone—UGT1A9—Metapathway biotransformation—COMT—endogenous depression	0.00239	0.00396	CbGpPWpGaD
Ketobemidone—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.00239	0.00395	CbGpPWpGaD
Ketobemidone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR1A—endogenous depression	0.00238	0.00393	CbGpPWpGaD
Ketobemidone—OPRK1—GPCRs, Class A Rhodopsin-like—HTR7—endogenous depression	0.00235	0.00388	CbGpPWpGaD
Ketobemidone—OPRM1—GPCRs, Class A Rhodopsin-like—HTR1A—endogenous depression	0.00234	0.00388	CbGpPWpGaD
Ketobemidone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2C—endogenous depression	0.00229	0.0038	CbGpPWpGaD
Ketobemidone—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR7—endogenous depression	0.00229	0.00379	CbGpPWpGaD
Ketobemidone—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.00227	0.00375	CbGpPWpGaD
Ketobemidone—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2C—endogenous depression	0.00226	0.00375	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR ligand binding—ADM—endogenous depression	0.00224	0.00371	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR ligand binding—OXT—endogenous depression	0.00214	0.00355	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR ligand binding—CRH—endogenous depression	0.00214	0.00355	CbGpPWpGaD
Ketobemidone—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.00213	0.00353	CbGpPWpGaD
Ketobemidone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.0021	0.00348	CbGpPWpGaD
Ketobemidone—OPRM1—Class A/1 (Rhodopsin-like receptors)—OXT—endogenous depression	0.00209	0.00345	CbGpPWpGaD
Ketobemidone—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.00207	0.00343	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR ligand binding—HTR1A—endogenous depression	0.00206	0.00341	CbGpPWpGaD
Ketobemidone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR7—endogenous depression	0.00201	0.00333	CbGpPWpGaD
Ketobemidone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR1A—endogenous depression	0.00201	0.00332	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR ligand binding—HTR2C—endogenous depression	0.00199	0.0033	CbGpPWpGaD
Ketobemidone—CYP2B6—Biological oxidations—CYP2D6—endogenous depression	0.00199	0.0033	CbGpPWpGaD
Ketobemidone—OPRM1—GPCRs, Class A Rhodopsin-like—HTR7—endogenous depression	0.00198	0.00328	CbGpPWpGaD
Ketobemidone—PTGS1—Biological oxidations—COMT—endogenous depression	0.00198	0.00327	CbGpPWpGaD
Ketobemidone—PTGS1—Biological oxidations—MAOA—endogenous depression	0.00196	0.00325	CbGpPWpGaD
Ketobemidone—CYP2B6—Metapathway biotransformation—CYP2D6—endogenous depression	0.00196	0.00325	CbGpPWpGaD
Ketobemidone—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.00194	0.00322	CbGpPWpGaD
Ketobemidone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2C—endogenous depression	0.00194	0.00321	CbGpPWpGaD
Ketobemidone—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.00192	0.00317	CbGpPWpGaD
Ketobemidone—OPRD1—Peptide ligand-binding receptors—POMC—endogenous depression	0.00191	0.00316	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR ligand binding—ADM—endogenous depression	0.0019	0.00314	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR ligand binding—CRH—endogenous depression	0.00188	0.00311	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR ligand binding—OXT—endogenous depression	0.00188	0.00311	CbGpPWpGaD
Ketobemidone—OPRD1—GPCRs, Class A Rhodopsin-like—HTR2A—endogenous depression	0.00187	0.0031	CbGpPWpGaD
Ketobemidone—CYP2B6—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.00184	0.00304	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR ligand binding—HTR1A—endogenous depression	0.00181	0.00299	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR ligand binding—HTR2C—endogenous depression	0.00175	0.00289	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR ligand binding—HTR7—endogenous depression	0.00175	0.00289	CbGpPWpGaD
Ketobemidone—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.00171	0.00283	CbGpPWpGaD
Ketobemidone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.0017	0.00282	CbGpPWpGaD
Ketobemidone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR7—endogenous depression	0.0017	0.00281	CbGpPWpGaD
Ketobemidone—CYP2C8—Biological oxidations—CYP2D6—endogenous depression	0.00169	0.00279	CbGpPWpGaD
Ketobemidone—OPRK1—Peptide ligand-binding receptors—POMC—endogenous depression	0.00168	0.00277	CbGpPWpGaD
Ketobemidone—CYP2C8—Metapathway biotransformation—CYP2D6—endogenous depression	0.00166	0.00275	CbGpPWpGaD
Ketobemidone—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2A—endogenous depression	0.00164	0.00272	CbGpPWpGaD
Ketobemidone—OPRD1—G alpha (i) signalling events—POMC—endogenous depression	0.00161	0.00267	CbGpPWpGaD
Ketobemidone—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—endogenous depression	0.00161	0.00266	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR ligand binding—CRH—endogenous depression	0.00159	0.00263	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR ligand binding—OXT—endogenous depression	0.00159	0.00263	CbGpPWpGaD
Ketobemidone—UGT1A9—Biological oxidations—POMC—endogenous depression	0.00157	0.0026	CbGpPWpGaD
Ketobemidone—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.00156	0.00258	CbGpPWpGaD
Ketobemidone—CYP2C8—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.00155	0.00257	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR ligand binding—HTR7—endogenous depression	0.00153	0.00253	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR ligand binding—HTR1A—endogenous depression	0.00153	0.00253	CbGpPWpGaD
Ketobemidone—CYP2B6—Biological oxidations—COMT—endogenous depression	0.00151	0.0025	CbGpPWpGaD
Ketobemidone—CYP2C19—Biological oxidations—CYP2D6—endogenous depression	0.0015	0.00249	CbGpPWpGaD
Ketobemidone—CYP2B6—Biological oxidations—MAOA—endogenous depression	0.0015	0.00248	CbGpPWpGaD
Ketobemidone—CYP2B6—Metapathway biotransformation—COMT—endogenous depression	0.00149	0.00246	CbGpPWpGaD
Ketobemidone—CYP2C19—Metapathway biotransformation—CYP2D6—endogenous depression	0.00148	0.00246	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR ligand binding—HTR2C—endogenous depression	0.00148	0.00244	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—ADM—endogenous depression	0.00145	0.00239	CbGpPWpGaD
Ketobemidone—OPRM1—Peptide ligand-binding receptors—POMC—endogenous depression	0.00142	0.00234	CbGpPWpGaD
Ketobemidone—OPRK1—G alpha (i) signalling events—POMC—endogenous depression	0.00141	0.00234	CbGpPWpGaD
Ketobemidone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2A—endogenous depression	0.00141	0.00233	CbGpPWpGaD
Ketobemidone—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—endogenous depression	0.00139	0.0023	CbGpPWpGaD
Ketobemidone—CYP2C19—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.00139	0.0023	CbGpPWpGaD
Ketobemidone—CYP2C9—Biological oxidations—CYP2D6—endogenous depression	0.00137	0.00227	CbGpPWpGaD
Ketobemidone—CYP2C9—Metapathway biotransformation—CYP2D6—endogenous depression	0.00135	0.00224	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—ADM—endogenous depression	0.00131	0.00217	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR ligand binding—HTR7—endogenous depression	0.00129	0.00214	CbGpPWpGaD
Ketobemidone—OPRD1—Class A/1 (Rhodopsin-like receptors)—POMC—endogenous depression	0.00128	0.00212	CbGpPWpGaD
Ketobemidone—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.00128	0.00212	CbGpPWpGaD
Ketobemidone—PTGS1—Biological oxidations—POMC—endogenous depression	0.00128	0.00212	CbGpPWpGaD
Ketobemidone—CYP2C8—Biological oxidations—COMT—endogenous depression	0.00128	0.00211	CbGpPWpGaD
Ketobemidone—CYP2C8—Biological oxidations—MAOA—endogenous depression	0.00127	0.0021	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—ADM—endogenous depression	0.00127	0.0021	CbGpPWpGaD
Ketobemidone—CYP2C9—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.00127	0.00209	CbGpPWpGaD
Ketobemidone—CYP2C8—Metapathway biotransformation—COMT—endogenous depression	0.00126	0.00209	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR ligand binding—HTR2A—endogenous depression	0.00122	0.00202	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—CRH—endogenous depression	0.00121	0.002	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—OXT—endogenous depression	0.00121	0.002	CbGpPWpGaD
Ketobemidone—OPRM1—G alpha (i) signalling events—POMC—endogenous depression	0.00119	0.00198	CbGpPWpGaD
Ketobemidone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—endogenous depression	0.00119	0.00197	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—HTR1A—endogenous depression	0.00117	0.00193	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—ADM—endogenous depression	0.00115	0.0019	CbGpPWpGaD
Ketobemidone—CYP2C19—Biological oxidations—COMT—endogenous depression	0.00114	0.00189	CbGpPWpGaD
Ketobemidone—CYP2C19—Biological oxidations—MAOA—endogenous depression	0.00113	0.00187	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—HTR2C—endogenous depression	0.00113	0.00186	CbGpPWpGaD
Ketobemidone—CYP2C19—Metapathway biotransformation—COMT—endogenous depression	0.00112	0.00186	CbGpPWpGaD
Ketobemidone—OPRK1—Class A/1 (Rhodopsin-like receptors)—POMC—endogenous depression	0.00112	0.00186	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—OXT—endogenous depression	0.0011	0.00182	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—CRH—endogenous depression	0.0011	0.00182	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR ligand binding—HTR2A—endogenous depression	0.00107	0.00177	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—ADM—endogenous depression	0.00107	0.00177	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—CRH—endogenous depression	0.00106	0.00176	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—OXT—endogenous depression	0.00106	0.00176	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—HTR1A—endogenous depression	0.00106	0.00175	CbGpPWpGaD
Ketobemidone—CYP2C9—Biological oxidations—COMT—endogenous depression	0.00104	0.00172	CbGpPWpGaD
Ketobemidone—CYP2C9—Biological oxidations—MAOA—endogenous depression	0.00103	0.00171	CbGpPWpGaD
Ketobemidone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.00103	0.0017	CbGpPWpGaD
Ketobemidone—CYP2C9—Metapathway biotransformation—COMT—endogenous depression	0.00103	0.0017	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—HTR2C—endogenous depression	0.00102	0.00169	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—HTR1A—endogenous depression	0.00102	0.00169	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—HTR2C—endogenous depression	0.000987	0.00163	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—HTR7—endogenous depression	0.000986	0.00163	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR ligand binding—POMC—endogenous depression	0.000976	0.00162	CbGpPWpGaD
Ketobemidone—CYP2B6—Biological oxidations—POMC—endogenous depression	0.000976	0.00161	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—ADM—endogenous depression	0.000973	0.00161	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—CRH—endogenous depression	0.000964	0.0016	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—OXT—endogenous depression	0.000964	0.0016	CbGpPWpGaD
Ketobemidone—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—endogenous depression	0.00095	0.00157	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—HTR1A—endogenous depression	0.000928	0.00154	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR ligand binding—HTR2A—endogenous depression	0.000906	0.0015	CbGpPWpGaD
Ketobemidone—CYP3A4—Biological oxidations—CYP2D6—endogenous depression	0.000905	0.0015	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—TPH1—endogenous depression	0.000904	0.0015	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—OXT—endogenous depression	0.000898	0.00149	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—CRH—endogenous depression	0.000898	0.00149	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—HTR2C—endogenous depression	0.000897	0.00148	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—HTR7—endogenous depression	0.000896	0.00148	CbGpPWpGaD
Ketobemidone—CYP3A4—Metapathway biotransformation—CYP2D6—endogenous depression	0.000892	0.00148	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—HTR7—endogenous depression	0.000865	0.00143	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—HTR1A—endogenous depression	0.000864	0.00143	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR ligand binding—POMC—endogenous depression	0.000856	0.00142	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—WASF2—endogenous depression	0.000848	0.0014	CbGpPWpGaD
Ketobemidone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.000835	0.00138	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—HTR2C—endogenous depression	0.000834	0.00138	CbGpPWpGaD
Ketobemidone—CYP2C8—Biological oxidations—POMC—endogenous depression	0.000826	0.00137	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—CRH—endogenous depression	0.000815	0.00135	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—OXT—endogenous depression	0.000815	0.00135	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—WASF1—endogenous depression	0.000813	0.00135	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—HTR7—endogenous depression	0.000785	0.0013	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—HTR1A—endogenous depression	0.000785	0.0013	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—ADM—endogenous depression	0.000775	0.00128	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—HTR2C—endogenous depression	0.000758	0.00125	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—WASF2—endogenous depression	0.000743	0.00123	CbGpPWpGaD
Ketobemidone—CYP2C19—Biological oxidations—POMC—endogenous depression	0.000737	0.00122	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—TPH1—endogenous depression	0.000737	0.00122	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—HTR7—endogenous depression	0.000731	0.00121	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR ligand binding—POMC—endogenous depression	0.000723	0.0012	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—WASF1—endogenous depression	0.000713	0.00118	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—HTR2A—endogenous depression	0.000691	0.00114	CbGpPWpGaD
Ketobemidone—CYP3A4—Biological oxidations—COMT—endogenous depression	0.000686	0.00113	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—TPH2—endogenous depression	0.000685	0.00113	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—CACNB2—endogenous depression	0.000685	0.00113	CbGpPWpGaD
Ketobemidone—CYP3A4—Biological oxidations—MAOA—endogenous depression	0.000681	0.00113	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—ADM—endogenous depression	0.00068	0.00113	CbGpPWpGaD
Ketobemidone—CYP3A4—Metapathway biotransformation—COMT—endogenous depression	0.000676	0.00112	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—DPYD—endogenous depression	0.000674	0.00112	CbGpPWpGaD
Ketobemidone—CYP2C9—Biological oxidations—POMC—endogenous depression	0.000672	0.00111	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—HTR7—endogenous depression	0.000664	0.0011	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—OXT—endogenous depression	0.00065	0.00108	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CRH—endogenous depression	0.00065	0.00108	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—WASF2—endogenous depression	0.000628	0.00104	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—HTR2A—endogenous depression	0.000627	0.00104	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—CACNA1C—endogenous depression	0.000626	0.00104	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—HTR1A—endogenous depression	0.000625	0.00104	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—HTR2A—endogenous depression	0.000606	0.001	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—HTR2C—endogenous depression	0.000604	0.001	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—WASF1—endogenous depression	0.000602	0.000997	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism of lipids and lipoproteins—POMC—endogenous depression	0.000602	0.000997	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—ADM—endogenous depression	0.000575	0.000951	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CRH—endogenous depression	0.00057	0.000943	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—OXT—endogenous depression	0.00057	0.000943	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—TPH1—endogenous depression	0.000562	0.00093	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—TPH2—endogenous depression	0.000558	0.000924	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—CACNB2—endogenous depression	0.000558	0.000924	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—POMC—endogenous depression	0.000552	0.000913	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—HTR2A—endogenous depression	0.00055	0.00091	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—DPYD—endogenous depression	0.000549	0.000909	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—HTR1A—endogenous depression	0.000548	0.000908	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—CYP2D6—endogenous depression	0.000547	0.000906	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—HTR2C—endogenous depression	0.00053	0.000877	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—HTR7—endogenous depression	0.000529	0.000876	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—HTR2A—endogenous depression	0.000512	0.000847	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—CACNA1C—endogenous depression	0.000511	0.000845	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—POMC—endogenous depression	0.000501	0.000829	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism of lipids and lipoproteins—POMC—endogenous depression	0.000491	0.000813	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—POMC—endogenous depression	0.000484	0.000801	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—OXT—endogenous depression	0.000482	0.000797	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CRH—endogenous depression	0.000482	0.000797	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—TPH1—endogenous depression	0.000476	0.000788	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—HTR2A—endogenous depression	0.000465	0.000769	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—HTR7—endogenous depression	0.000464	0.000768	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—HTR1A—endogenous depression	0.000464	0.000767	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—HTR2C—endogenous depression	0.000448	0.000741	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—CYP2D6—endogenous depression	0.000446	0.000739	CbGpPWpGaD
Ketobemidone—CYP3A4—Biological oxidations—POMC—endogenous depression	0.000443	0.000734	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—POMC—endogenous depression	0.000439	0.000727	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—TPH2—endogenous depression	0.000426	0.000705	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—CACNB2—endogenous depression	0.000426	0.000705	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—TPH1—endogenous depression	0.000425	0.000703	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—DPYD—endogenous depression	0.000419	0.000694	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—COMT—endogenous depression	0.000415	0.000687	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—MAOA—endogenous depression	0.000412	0.000682	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—POMC—endogenous depression	0.000409	0.000677	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—HTR7—endogenous depression	0.000392	0.000649	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—CACNA1C—endogenous depression	0.00039	0.000645	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—TPH1—endogenous depression	0.000387	0.000641	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—POMC—endogenous depression	0.000371	0.000614	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—HTR2A—endogenous depression	0.000371	0.000613	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—TPH2—endogenous depression	0.000361	0.000597	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—CACNB2—endogenous depression	0.000361	0.000597	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—DPYD—endogenous depression	0.000355	0.000587	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—CYP2D6—endogenous depression	0.000341	0.000564	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—COMT—endogenous depression	0.000338	0.00056	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—MAOA—endogenous depression	0.000336	0.000556	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—CACNA1C—endogenous depression	0.00033	0.000546	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—HTR2A—endogenous depression	0.000325	0.000538	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—TPH2—endogenous depression	0.000322	0.000533	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—CACNB2—endogenous depression	0.000322	0.000533	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—endogenous depression	0.000317	0.000525	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—DPYD—endogenous depression	0.000317	0.000524	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—POMC—endogenous depression	0.000296	0.00049	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—CACNA1C—endogenous depression	0.000294	0.000487	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CACNB2—endogenous depression	0.000293	0.000486	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—TPH2—endogenous depression	0.000293	0.000486	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—DPYD—endogenous depression	0.000289	0.000478	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—CYP2D6—endogenous depression	0.000288	0.000477	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—POMC—endogenous depression	0.000283	0.000469	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—HTR2A—endogenous depression	0.000275	0.000455	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CACNA1C—endogenous depression	0.000268	0.000444	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—POMC—endogenous depression	0.000268	0.000444	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—POMC—endogenous depression	0.00026	0.00043	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—endogenous depression	0.000258	0.000427	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—COMT—endogenous depression	0.000258	0.000427	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—CYP2D6—endogenous depression	0.000257	0.000426	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—MAOA—endogenous depression	0.000256	0.000424	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—TPH1—endogenous depression	0.000255	0.000423	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CYP2D6—endogenous depression	0.000235	0.000388	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—POMC—endogenous depression	0.000219	0.000363	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—POMC—endogenous depression	0.000219	0.000362	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—COMT—endogenous depression	0.000218	0.000362	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—MAOA—endogenous depression	0.000217	0.000359	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—COMT—endogenous depression	0.000195	0.000323	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—MAOA—endogenous depression	0.000194	0.00032	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—TPH2—endogenous depression	0.000194	0.00032	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CACNB2—endogenous depression	0.000194	0.00032	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—DPYD—endogenous depression	0.00019	0.000315	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—COMT—endogenous depression	0.000178	0.000294	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CACNA1C—endogenous depression	0.000177	0.000293	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—MAOA—endogenous depression	0.000177	0.000292	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—POMC—endogenous depression	0.000167	0.000276	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CYP2D6—endogenous depression	0.000155	0.000256	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—POMC—endogenous depression	0.000141	0.000234	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—POMC—endogenous depression	0.000126	0.000209	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—COMT—endogenous depression	0.000117	0.000194	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—MAOA—endogenous depression	0.000116	0.000193	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—POMC—endogenous depression	0.000115	0.00019	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—POMC—endogenous depression	7.58e-05	0.000125	CbGpPWpGaD
